Clinical Trials Logo

HGPS clinical trials

View clinical trials related to HGPS.

Filter by:
  • None
  • Page 1

NCT ID: NCT03895528 Approved for marketing - Progeria Clinical Trials

Lonafarnib for Patients With Hutchinson-Gilford Progeria Syndrome or Progeroid Laminopathy

Start date: n/a
Phase:
Study type: Expanded Access

This treatment IND protocol will allow patients with HGPS and progeroid laminopathies access to lonafarnib, the only compound shown to have an effect on the HGPS disease process resulting in improved outcomes (Gordon et al, 2018). There are no approved treatments for HGPS and progeroid laminopathies.